Key result
New statin treatment linked to ~71% less carotid IMT progression over 10 years versus no treatment.
Why the study?
Randomized trials show statins slow carotid intima-media thickness progression with aging but typically have limited follow-up of 1 to 3 years, leaving real-life effects over 10 years unclear.
Does new statin treatment reduce the progression of carotid artery intima-media thickness over 10 years in 70-year-old individuals?
Observational (n=954)
Does new statin treatment reduce the progression of carotid artery intima-media thickness over 10 years in 70-year-old individuals?
In a real-world cohort of 70-year-olds, initiating statin therapy significantly attenuated the age-related progression of carotid intima-media thickness over a 10-year period.
Answers are grounded in this paper and cite their sources.
Statin initiation may slow IMT progression in older adults; leaves open causal benefit and need for outcome trials.
BACKGROUND AND AIMS: Randomized clinical trials (RCT) have shown statin treatment to slow down the increase in carotid artery intima-media thickness (IMT) seen with ageing. However, those RCTs usually have a limited follow-up (1-3 years). Here an observational study was used to investigate the real-life effect of new statin treatment over a 10-year follow-up. METHODS: In the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study, 954 individuals all aged 70 years at baseline were investigated regarding carotid artery IMT three times during 10 years (n = 771 at age 75, and n = 591 at age 80). RESULTS: At age 70, 503 subjects were statin-naïve and did not receive statin during the 10-year follow-up period (the never-statin group), while 197 subjects were statin-naïve but received statins during the follow-up period (the received-statin group). Low-density lipoprotein (LDL)-cholesterol increased over time in the never-statin group (+0.1 mmol/l, p = 0.0012), but decreased in the group receiving statin treatment (-1.1 mmol/l, p < 0.0001). The never-statin group increased significantly in IMT over the 10 years (+0.07 mm, p < 0.0001), while the numerical increase seen in the received-statin group was not significant (+0.02 mm, p = 0.22) A significant difference in the change in IMT over time was seen between the received-statin group and the never-statin group (p < 0.0001 for interaction between time and group, adjusted for a propensity score). CONCLUSIONS: This real-life observational study showed that new statin treatment reduced the increase in IMT seen over 10 years compared to subjects not treated with statins.
No takes yet. Share an insight, caveat, or question.
Lars Lind (2020) conducted an observational in Statin-naïve seniors (n=954). New statin treatment vs. No statin treatment (never-statin group) was evaluated on Change in carotid artery intima-media thickness (IMT) over 10 years (p=<0.0001). New statin treatment over 10 years reduced the progression of carotid artery intima-media thickness compared to no statin treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: